Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26419157 | 0.89 | HTT (0.30) | — | |
| SCHEMBL26420702 | 0.86 | CYP1A2 (0.39) | — | |
| SCHEMBL26427571 | 0.83 | CYP1A2 (0.31) | — | |
| SCHEMBL26419162 | 0.79 | — | — | |
| SCHEMBL15471220 | 0.74 | — | — | |
| SCHEMBL25565974 | 0.74 | HRH3 (0.31) | DRD2DRD3 | |
| SCHEMBL10035081 | 0.73 | DRD2 (0.40) | DRD2DRD3 | |
| SCHEMBL26419160 | 0.73 | — | — | |
| SCHEMBL9883846 | 0.71 | ATM (0.32) | — | |
| SCHEMBL25565978 | 0.70 | NCF1 (0.36) | DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128824-A1 | SPIRO RING-CONTAINING QUINAZOLINE COMPOUND | Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128824-A1 | SPIRO RING-CONTAINING QUINAZOLINE COMPOUND | KRAS, NRAS, HRAS | DRD2 4696/4885DRD3 4682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.